Skip to main content
Gulf Pharmaceutical Industries logo

Gulf Pharmaceutical Industries — Investor Relations & Filings

Ticker · JULPHAR ISIN · AEG000201018 Abu Dhabi Securities Exchange Manufacturing
Open in API
Filings indexed 360 across all filing types
Latest filing 2021-07-12 Regulatory Filings
Country AE United Arab Emirates
Listing Abu Dhabi Securities Exchange JULPHAR

About Gulf Pharmaceutical Industries

https://www.Julphar.net

Gulf Pharmaceutical Industries (Julphar) is a prominent pharmaceutical manufacturer and distributor. The company specializes in producing a diverse portfolio of medicines, vaccines, and consumer healthcare products, addressing a broad spectrum of health conditions. Julphar is recognized as one of the largest generic pharmaceutical manufacturers in the Middle East and North Africa, and a leading global producer of insulin. Utilizing internationally accredited, state-of-the-art facilities, it manufactures over one million medicine boxes daily, distributing products to more than 40 countries. The company's operations emphasize high quality and safety standards in its comprehensive manufacturing capabilities.

Recent filings

Filing Released Lang Actions
Gulf Pharmaceutical Industries Announcements
Regulatory Filings
2021-07-12 English
شركة الخليج للصناعات الدوائية بيانات صحفية عامة
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the acquisition of full control of Planet Pharmacies LLC by Gulf Pharmaceutical Industries (Julphar). It discusses the strategic rationale, expected financial impact starting from Q3 2021, and business expansion plans. There are no detailed financial statements, regulatory certifications, or voting results. The content focuses on a corporate transaction (acquisition) and its strategic implications rather than a merger filing or tender offer documentation. This fits best under Capital/Financing Update (CAP) as it relates to a significant change in ownership and capital structure through acquisition. The document length and content do not indicate it is a full annual or interim report, nor a regulatory filing or announcement of a report publication.
2021-07-12 Arabic
Gulf Pharmaceutical Industries General Press Release
M&A Activity Classification · 95% confidence The document is a press release announcing the acquisition of full control of Planet Pharmacies LLC by Gulf Pharmaceutical Industries (Julphar). It details the transaction, strategic rationale, and expected benefits to the company. There are no financial statements, detailed financial performance data, or regulatory form references. The content focuses on a corporate transaction (acquisition) and its strategic impact, which fits the category of M&A Activity. The document length is about 5,379 characters, which is consistent with a press release rather than a full report. Therefore, the appropriate classification is M&A Activity (TAR).
2021-07-12 English
شركة الخليج للصناعات الدوائية النظام الأساسي
Governance Information Classification · 95% confidence The document is titled 'Articles of Incorporation' for Gulf Pharmaceutical Industries (Julphar), detailing the company's foundational legal structure, board of directors, and amendments to the Articles of Association in compliance with UAE Companies Law. It includes detailed legal and governance provisions, definitions, and company objectives. This is a governance-related document outlining the company's internal rules and board structure rather than a financial report or announcement. It is not an Annual Report, Interim Report, or any financial statement. It is not a meeting presentation or voting result. The content fits the definition of Governance Information (CGR) as it details the company's internal rules, board structure, and governance practices.
2021-07-11 Arabic
Gulf Pharmaceutical Industries Article of Association
Governance Information Classification · 95% confidence The document is titled 'Articles of Incorporation' for Gulf Pharmaceutical Industries (Julphar), detailing the company's foundational legal structure, board of directors, and amendments to the Articles of Association in compliance with UAE Companies Law. It includes detailed governance and structural provisions rather than financial data or report summaries. This type of document is a governance-related filing outlining the company's internal rules and board structure. It is not an annual report, earnings release, or any financial statement. Therefore, the appropriate classification is Governance Information (CGR). The document length and content confirm it is the full governance document, not just an announcement or summary.
2021-07-11 English
شركة الخليج للصناعات الدوائية الافصاح
Notice of Dividend Amount Classification · 90% confidence The document text is in Arabic and appears to be an announcement related to shareholder matters, specifically mentioning dividends and shareholder meetings. The text references cash dividends for the period ending March 2015 and mentions shareholders' receipt of dividends. The document length is short (2705 characters), and the content seems to be an announcement rather than a full report. There is no detailed financial data or comprehensive financial statements present. The document also includes a URL to the investor relations section of the company's website, suggesting it is an announcement rather than the report itself. Given these factors, the document is best classified as a Notice of Dividend Amount (DIV), which typically announces dividend amounts and payment details to shareholders.
2021-07-10 Arabic

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.